Literature DB >> 6658901

Subarachnoid hemorrhage in New Zealand: an epidemiological study.

R Bonita, R Beaglehole, J D North.   

Abstract

To examine long-term trends in subarachnoid hemorrhage (SAH) mortality and morbidity, an analysis of routinely available information is presented for the 20 year period from 1959. To document the current incidence and case fatality of SAH, the results of a large scale community-based study in the Auckland region are presented. SAH mortality rates for both men and women, especially women, have declined since the mid-1970's. The decline appears to be real, and is most striking in the 45-64 year age groups. A corresponding decline in discharge rates from hospital has also occurred in these age groups. In contrast, cases fatality rates have remained stable at about 42% for the 20 year period under review. The community-based study identified 92 cases in a total population of 829,464 in a twelve month period. The age standardised incidence rates were 13.4 and 15.8 per 100,000 for men and women respectively. In the age group 25-35 years, the incidence rate was particularly high at 8.5/100,000. Case fatality at 28 days was 52%. A decline in incidence appears the most likely explanation for the overall decline in national mortality.

Entities:  

Mesh:

Year:  1983        PMID: 6658901     DOI: 10.1161/01.str.14.3.342

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Has plasma renin activity a prognostic significance in subarachnoid haemorrhage?

Authors:  G Hamann; T Stober; K Schimrigk
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Xanthochromia revisited: a re-evaluation of lumbar puncture and CT scanning in the diagnosis of subarachnoid haemorrhage.

Authors:  A MacDonald; A D Mendelow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

3.  Effect of ultra-early referral on management outcome in subarachnoid haemorrhage.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Endovascular management for intracranial ruptured aneurysms in elderly patients: outcome and technical aspects.

Authors:  F Mont'alverne; M Musacchio; V Tolentino; C Riquelme; A Tournade
Journal:  Neuroradiology       Date:  2005-05-11       Impact factor: 2.804

5.  Spontaneous subarachnoid haemorrhage and ruptured aneurysms in the Middle East. A myth revisited.

Authors:  G J Nogueira
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

6.  30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies.

Authors:  Valery L Feigin; Rita V Krishnamurthi; Suzanne Barker-Collo; Kathryn M McPherson; P Alan Barber; Varsha Parag; Bruce Arroll; Derrick A Bennett; Martin Tobias; Amy Jones; Emma Witt; Paul Brown; Max Abbott; Rohit Bhattacharjee; Elaine Rush; Flora Minsun Suh; Alice Theadom; Yogini Rathnasabapathy; Braden Te Ao; Priya G Parmar; Craig Anderson; Ruth Bonita
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

7.  The Ottawa SAH search algorithms: protocol for a multi- centre validation study of primary subarachnoid hemorrhage prediction models using health administrative data (the SAHepi prediction study protocol).

Authors:  S W English; L McIntyre; V Saigle; M Chassé; D A Fergusson; A F Turgeon; F Lauzier; D Griesdale; A Garland; R Zarychanski; A Algird; C van Walraven
Journal:  BMC Med Res Methodol       Date:  2018-09-15       Impact factor: 4.615

8.  Aneurysmal subarachnoid hemorrhage in third and fourth decades of life.

Authors:  Su-Yong Kim; Chul-Hee Lee; In Sung Park; Jae Ha Hwang; Soo Hyun Hwang; Jong Woo Han
Journal:  J Korean Neurosurg Soc       Date:  2012-09-30

9.  Subarachnoid hemorrhage admissions retrospectively identified using a prediction model.

Authors:  Shane W English; Lauralyn McIntyre; Dean Fergusson; Alexis Turgeon; Marlise P Dos Santos; Cheemun Lum; Michaël Chassé; John Sinclair; Alan Forster; Carl van Walraven
Journal:  Neurology       Date:  2016-09-14       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.